Chronic inflammatory pain
Conditions
Interventions
Experimental group:Loxoprofen Sodium Gel Patch
Sponsors
Shandong Provincial Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients voluntarily agreed to participate in this study and signed a written informed consent; 2. Aged 18 to 75 years, no gender limit; 3. Patients diagnosed with chronic inflammatory pain after clinical diagnosis, including osteoarthritis, frozen shoulder, etc.; 4. No history of bleeding, asthma, severe heart, liver and kidney insufficiency, non-steroidal drug allergy, etc.; 5. The research/control drugs used by the patients are in the drug list prescribed in this study.
Exclusion criteria
Exclusion criteria: 1. Patients with bronchial asthma; 2. Pregnant and lactating patients or patients of childbearing age who are about to conceive; 3. Known allergic to non-steroidal anti-inflammatory drugs; 4. Patients who have participated in clinical studies of other drugs within 1 month; 5. Other concomitant diseases or complications that may affect the observation of curative effect (skin damage, infection, rash).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effectiveness of treatment;Visual analogue scale scoring;Limb swelling value;Medical side effects;Recurrence rate; | — |
Countries
China
Contacts
Public ContactSun Tao
Outcome results
None listed